“Profile of Federal Purchases of Insulins in Brazil: The Impact of Biosimilars Entry”. Research, Society and Development, vol. 11, no. 4, Mar. 2022, p. e1511427073, https://doi.org/10.33448/rsd-v11i4.27073.